Prompetchara, Eakachai
Ketloy, Chutitorn http://orcid.org/0000-0002-7043-8062
Alameh, Mohamad-Gabriel http://orcid.org/0000-0002-5672-6930
Tharakhet, Kittipan
Kaewpang, Papatsara
Yostrerat, Nongnaphat
Pitakpolrat, Patrawadee
Buranapraditkun, Supranee
Manopwisedjaroen, Suwimon http://orcid.org/0000-0002-7571-8733
Thitithanyanont, Arunee
Jongkaewwattana, Anan
Hunsawong, Taweewan
Im-Erbsin, Rawiwan
Reed, Matthew
Wijagkanalan, Wassana
Patarakul, Kanitha
Techawiwattanaboon, Teerasit
Palaga, Tanapat
Lam, Kieu http://orcid.org/0000-0002-1965-5491
Heyes, James
Weissman, Drew
Ruxrungtham, Kiat
Article History
Received: 13 September 2022
Accepted: 24 March 2023
First Online: 21 April 2023
Competing interests
: DW, and MGA are named on patents that describe lipid nanoparticles for delivery of nucleic acid therapeutics, including mRNA and the use of modified mRNA in lipid nanoparticles as a vaccine platform. KR, DW, MGA, CK, EP, and SB are co-inventors of the submitted ChulaCov19 mRNA vaccine’s Patent. KL and JH are employees of Genevant Sciences Corporation and are named on patent describing lipid nanoparticles. WW is an employee of BioNet-Asia, Co. Ltd. We have disclosed those interests fully to their affiliations, and we have in place an approved plan for managing any potential conflicts arising from licensing of the patents. The remaining authors declare no competing interests.